Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:17   Issue:3
Pp: 205-205
Hiroshi Yamazaki
DOI: 10.2174/138920021703160212165628

Cannabinoids and Cytochrome P450 Interactions

Volume:17   Issue:3
Pp: 206-226
Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, Miroslav Turjap, Alexandra Šulcová, Lumír Hanuš and Jan Juřica
DOI: 10.2174/1389200217666151210142051

Influence of CYP3A5 Polymorphism on the Pharmacokinetics of Psychiatric Drugs

Volume:17   Issue:3
Pp: 227-236
Georgia Ragia, Marja-Liisa Dahl and Vangelis G. Manolopoulos
DOI: 10.2174/1389200217666151210125831

Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department

Volume:17   Issue:3
Pp: 253-270
Anna-Karin Sohlenius-Sternbeck, Juliette Janson, Johan Bylund, Pawel Baranczewski, Anna Breitholtz-Emanuelsson, Yin Hu, Carrie Tsoi, Anders Lindgren, Olle Gissberg, Tjerk Bueters, Sveinn Briem, Sanja Juric, Jenny Johansson, Margareta Bergh and Janet Hoogstraate
DOI: 10.2174/1389200217666151210125637

Variation of Pharmacokinetic Profiles of Some Antidiabetic Drugs from Nanostructured Formulations Administered Through Pulmonary Route

Volume:17   Issue:3
Pp: 271-278
Biswajit Mukherjee, Paramita Paul, Ankan Choudhury, Sanchari Bhattacharya, Ruma Maji and Lopamudra Dutta
DOI: 10.2174/1389200216666151015115503

Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology

Volume:17   Issue:3
Pp: 279-291
Jianting Chen, Hao Pan, Tiantian Ye, Dandan Liu, Qijun Li, Fen Chen, Xinggang Yang and Weisan Pan
DOI: 10.2174/1389200216666151015115706

Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases

Volume:17   Issue:3
Pp: 303-306
Federica Laudisi, Vincenzo Dinallo, Davide Di Fusco and Giovanni Monteleone
DOI: 10.2174/1389200217666151210130103